Sequential Bone-Marrow Cell Delivery of VEGFA/S1P Improves Vascularization and Limits Adverse Cardiac Remodeling After Myocardial Infarction in Mice

Human Gene Therapy
Magdalena M ŻakAlicia G Arroyo

Abstract

Microvascular dysfunction and resulting tissue hypoxia is a major contributor to the pathogenesis and evolution of cardiovascular diseases (CVD). Diverse gene and cell therapies have been proposed to preserve the microvasculature or boost angiogenesis in CVD, with moderate benefit. This study tested in vivo the impact of sequential delivery by bone-marrow (BM) cells of the pro-angiogenic factors vascular endothelial growth factor (VEGFA) and sphingosine-1-phosphate (S1P) in a myocardial infarction model. For that, mouse BM cells were transduced with lentiviral vectors coding for VEGFA or sphingosine kinase (SPHK1), which catalyzes S1P production, and injected them intravenously 4 and 7 days after cardiac ischemia-reperfusion in mice. Sequential delivery by transduced BM cells of VEGFA and S1P led to increased endothelial cell numbers and shorter extravascular distances in the infarct zone, which support better oxygen diffusion 28 days post myocardial infarction, as shown by automated 3D image analysis of the microvasculature. Milder effects were observed in the remote zone, together with increased proportion of capillaries. BM cells delivering VEGFA and S1P also decreased myofibroblast abundance and restricted adverse cardiac r...Continue Reading

References

Jan 20, 1999·Cardiovascular Research·J J LopezM Simons
Mar 19, 2003·Circulation·Timothy D HenryUNKNOWN VIVA Investigators
May 16, 2003·The New England Journal of Medicine·Mariell Jessup, Susan Brozena
Feb 27, 2004·Biochemical and Biophysical Research Communications·X HaoC Sylvén
Nov 16, 2004·The American Journal of Cardiology·Selwyn P WongHarvey D White
Apr 11, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Masaya TakahashiKimikazu Hamano
Jul 29, 2006·Circulation Research·Christina A PacakBarry J Byrne
Sep 16, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Hideto SanoNobuyuki Takakura
Sep 23, 2006·The New England Journal of Medicine·Volker SchächingerUNKNOWN REPAIR-AMI Investigators
Nov 21, 2007·The Journal of Experimental Medicine·Matthias NahrendorfMikael J Pittet
Mar 4, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Karl H SchuleriJoshua M Hare
Mar 8, 2008·Circulation Research·Jeniter E HughesCatherine C Hedrick
Jun 4, 2008·Current Opinion in Cardiology·Burkert Pieske, Rolf Wachter
Apr 9, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Duncan J StewartUNKNOWN NORTHERN Trial Investigators
Dec 2, 2009·Nature Reviews. Cardiology·Susanne W M van den BorneJagat Narula
Dec 10, 2009·Circulation. Heart Failure·Birgit AssmusUNKNOWN REPAIR-AMI Investigators
Jan 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Zhengxian TaoHua Su
May 5, 2011·World Journal of Biological Chemistry·Yutaka MatsuiToshimitsu Uede
Dec 24, 2011·Nature Protocols·Marianne BakerKairbaan Hodivala-Dilke
Jun 30, 2012·Nature Methods·Johannes SchindelinAlbert Cardona
Jul 27, 2012·Cell Reports·Mario Leonardo SquadritoMichele De Palma
Sep 15, 2012·Biochimica Et Biophysica Acta·F van den AkkerJ P G Sluijter
Feb 9, 2013·Circulation Research·Keehoon JungSeok Hyun Yun
Jul 17, 2013·Nature Reviews. Cardiology·Ziad TaimehRoberto Bolli
Oct 19, 2013·Physiological Reviews·Jean-Sébastien SilvestreBernard I Lévy
Mar 19, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Christian Waeber, Thomas Walther
Oct 2, 2015·Comprehensive Physiology·Nikolaos G Frangogiannis
Jun 22, 2016·Cell and Tissue Research·Virpi Talman, Heikki Ruskoaho
Jun 25, 2016·Circulation Research·Sumanth D Prabhu, Nikolaos G Frangogiannis
Jul 23, 2016·Circulation Research·Hendrik B SagerMatthias Nahrendorf
Jan 27, 2017·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Apr 1, 2017·Circulation Research·Jaume AgueroKiyotake Ishikawa
May 13, 2017·Circulation Research·Tariq Hamid, Sumanth D Prabhu
Jul 1, 2017·Current Cardiology Reports·Ankeet S BhattEric J Velazquez
Jul 29, 2017·Oxidative Medicine and Cellular Longevity·Leonardo SchironeGiacomo Frati

❮ Previous
Next ❯

Citations

Mar 8, 2021·International Journal of Pharmaceutics·Kaoutar ZianiJose Luis Pedraz
Mar 30, 2021·Advanced Drug Delivery Reviews·Matthew A BorrelliSteven R Little

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry gating
SMA
confocal microscopy

Software Mentioned

ImageJ
Imaris
FlowJo

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Małgorzata KnappWłodzimierz Musiał
© 2022 Meta ULC. All rights reserved